KZR - Kezar Life Sciences, Inc.
6.94
0.110 1.585%
Share volume: 26,421
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$6.83
0.11
0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-09-2024 | 08-13-2024 | 11-12-2024 | 03-25-2025 | 05-13-2025 | 08-13-2025 | 11-12-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | nan% | nan% | ||||
| Operating expenses | 23.711 M | 21.901 M | 21.948 M | 21.575 M | 17.629 M | 14.599 M | 12.253 M | |
| Selling general and admin | 6.539 M | 5.603 M | 5.706 M | 5.545 M | 5.449 M | 5.016 M | 5.339 M | |
| Research and development | 17.172 M | 16.298 M | 16.242 M | 16.030 M | 12.180 M | 9.583 M | 6.914 M | |
| Total expenses | 23.711 M | 23.383 M | 21.948 M | 21.563 M | 17.629 M | 14.599 M | 11.715 M | |
| -1.38% | -6.14% | -1.75% | -18.24% | -17.19% | -19.75% | |||
| Operating income | -23.711 M | -23.383 M | -21.948 M | -21.563 M | -17.629 M | -14.599 M | -11.715 M | |
| Ebit | -23.711 M | -23.383 M | -21.948 M | -21.563 M | -17.629 M | -14.599 M | -11.715 M | |
| Pretax income | -21.658 M | -21.547 M | -20.313 M | -20.218 M | -16.556 M | -13.704 M | -11.227 M | |
| -0.51% | -5.73% | -0.47% | -18.11% | -17.23% | -18.08% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -21.658 M | -21.547 M | -20.313 M | -20.218 M | -16.556 M | -13.704 M | -11.227 M | |
| 0.51% | 5.73% | 0.47% | 18.11% | 17.23% | 18.08% |